Paola Argiento
Overview
Explore the profile of Paola Argiento including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1046
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benincasa G, Pepin M, Russo V, Cacciatore F, DAlto M, Argiento P, et al.
Basic Res Cardiol
. 2024 Dec;
PMID: 39725721
Novel biomarkers are needed to better identify-and distinguish-heart failure with preserved ejection fraction (HFpEF) from other clinical phenotypes. The goal of our study was to identify epigenetic-sensitive biomarkers useful to...
2.
DAlto M, Romeo E, Argiento P, Vergara A, Caiazza E, Orlando A, et al.
Int J Cardiol Congenit Heart Dis
. 2024 Dec;
17:100526.
PMID: 39711769
Pulmonary arterial hypertension (PAH) is defined as increase in mean pulmonary arterial pressure and pulmonary vascular resistance (PVR). It can be associated with congenital heart disease (CHD) with the following...
3.
Argiento P, DAgostino A, Castaldo R, Franzese M, Mazzola M, Grunig E, et al.
Comput Struct Biotechnol J
. 2024 Dec;
24:746-753.
PMID: 39687751
Background: Pulmonary hypertension (PH) is a pathophysiological problem that may involve several clinical symptoms and be linked to various respiratory and cardiovascular illnesses. Its diagnosis is made invasively by Right...
4.
Vergara A, Orlando A, Caiazza E, Vettori S, Cuomo G, Argiento P, et al.
J Cardiovasc Dev Dis
. 2024 Sep;
11(9).
PMID: 39330332
Background: In systemic sclerosis (SSc), cardiac involvement is frequent, heterogeneous, and related to a poor prognosis. Due to a longer life expectancy, the development of degenerative aortic stenosis (AS) is...
5.
Manzi G, Benza R, Argiento P, Casu G, Corda M, Correale M, et al.
Vascul Pharmacol
. 2024 Sep;
157:107432.
PMID: 39265796
Despite the innovations introduced in the 2022 European Society of Cardiology/European Respiratory Society Guidelines on Pulmonary Hypertension, risk discrimination and management of pulmonary arterial hypertension (PAH) patients at intermediate risk...
6.
Guazzi M, Novello G, Bursi F, Caretti A, Furlotti N, Arena R, et al.
ESC Heart Fail
. 2024 Aug;
PMID: 39118416
Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers...
7.
Ghio S, Badagliacca R, DAlto M, Scelsi L, Argiento P, Brunetti N, et al.
J Heart Lung Transplant
. 2024 Jun;
43(10):1668-1676.
PMID: 38942159
Background: Right ventricular (RV) imaging has not a definite role in risk stratification of pulmonary arterial hypertension (PAH) patients. We tested the hypothesis that echocardiography-derived phenotypes, depicting different degrees of...
8.
DAlto M, Badagliacca R, Airo E, Ameri P, Argiento P, Garascia A, et al.
Vascul Pharmacol
. 2024 Apr;
155:107374.
PMID: 38642596
A comprehensive evaluation of risk, using multiple indices, is necessary to provide reliable prognostic information and guide therapy in pulmonary arterial hypertension (PAH). The current ESC/ERS guidelines suggest using a...
9.
Vatrano M, Manzi G, Picariello C, DAlto M, Enea I, Ghio S, et al.
G Ital Cardiol (Rome)
. 2024 Feb;
25(3):192-201.
PMID: 38410902
Pulmonary hypertension (PH) is a frequent pathological condition worldwide, mainly secondary to cardiovascular and respiratory diseases, with a poor prognosis. Pulmonary arterial hypertension (PAH) is a rare form that affects...
10.
DAlto M, Di Maio M, Argiento P, Romeo E, Rea G, Liccardo B, et al.
Eur J Heart Fail
. 2024 Feb;
26(4):817-824.
PMID: 38404257
Aims: Recent studies have shown that lung ultrasound-assessed pulmonary congestion is worse in heart failure when pulmonary vascular resistance (PVR) is increased, suggesting a paradoxical relationship between right heart failure...